Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study

PURPOSE: To identify the strongest variable(s) linked with the number of ranibizumab injections and outcomes in AURA, and to identify ways to improve outcomes using this association. METHODS: AURA was a large observational study that monitored visual acuity over a 2-year period in patients with neov...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eye (Lond)
Autors principals: Holz, F G, Tadayoni, R, Beatty, S, Berger, A R, Cereda, M G, Hykin, P, Staurenghi, G, Wittrup-Jensen, K, Nilsson, J, Kim, K, Sivaprasad, S
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4985685/
https://ncbi.nlm.nih.gov/pubmed/27197868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2016.90
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars